Benzodiazepines (BZD) are a class of psychoactive drugs with sedative, hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal symptoms.
In 2019, the market size of Benzodiazepine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benzodiazepine.
This report studies the global market size of Benzodiazepine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benzodiazepine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
Eli Lilly
Forest Laboratories
GlaxoSmithKline
H. Lundbeck
Johnson & Johnson
Merck & Co
Pfizer
Sanofi
Market Segment by Product Type
Long acting
Short acting
Market Segment by Application
Anxiety
Insomnia
Agitation
Seizures
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benzodiazepine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benzodiazepine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benzodiazepine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Benzodiazepine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benzodiazepine.
This report studies the global market size of Benzodiazepine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benzodiazepine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
Eli Lilly
Forest Laboratories
GlaxoSmithKline
H. Lundbeck
Johnson & Johnson
Merck & Co
Pfizer
Sanofi
Market Segment by Product Type
Long acting
Short acting
Market Segment by Application
Anxiety
Insomnia
Agitation
Seizures
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benzodiazepine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benzodiazepine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benzodiazepine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Benzodiazepine Market Size Growth Rate by Type (2019-2025)
1.3.2 Long acting
1.3.3 Short acting
1.4 Market Segment by Application
1.4.1 Global Benzodiazepine Market Share by Application (2019-2025)
1.4.2 Anxiety
1.4.3 Insomnia
1.4.4 Agitation
1.4.5 Seizures
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Benzodiazepine Market Size
2.1.1 Global Benzodiazepine Revenue 2014-2025
2.1.2 Global Benzodiazepine Sales 2014-2025
2.2 Benzodiazepine Growth Rate by Regions
2.2.1 Global Benzodiazepine Sales by Regions 2014-2019
2.2.2 Global Benzodiazepine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Benzodiazepine Sales by Manufacturers
3.1.1 Benzodiazepine Sales by Manufacturers 2014-2019
3.1.2 Benzodiazepine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Benzodiazepine Revenue by Manufacturers (2014-2019)
3.2.2 Benzodiazepine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Benzodiazepine Market Concentration Ratio (CR5 and HHI)
3.3 Benzodiazepine Price by Manufacturers
3.4 Key Manufacturers Benzodiazepine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Benzodiazepine Market
3.6 Key Manufacturers Benzodiazepine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Long acting Sales and Revenue (2014-2019)
4.1.2 Short acting Sales and Revenue (2014-2019)
4.2 Global Benzodiazepine Sales Market Share by Type
4.3 Global Benzodiazepine Revenue Market Share by Type
4.4 Benzodiazepine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Benzodiazepine Sales by Application
6 United States
6.1 United States Benzodiazepine Breakdown Data by Company
6.2 United States Benzodiazepine Breakdown Data by Type
6.3 United States Benzodiazepine Breakdown Data by Application
7 European Union
7.1 European Union Benzodiazepine Breakdown Data by Company
7.2 European Union Benzodiazepine Breakdown Data by Type
7.3 European Union Benzodiazepine Breakdown Data by Application
8 China
8.1 China Benzodiazepine Breakdown Data by Company
8.2 China Benzodiazepine Breakdown Data by Type
8.3 China Benzodiazepine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Benzodiazepine Breakdown Data by Company
9.2 Rest of World Benzodiazepine Breakdown Data by Type
9.3 Rest of World Benzodiazepine Breakdown Data by Application
9.4 Rest of World Benzodiazepine Breakdown Data by Countries
9.4.1 Rest of World Benzodiazepine Sales by Countries
9.4.2 Rest of World Benzodiazepine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Benzodiazepine
10.1.4 Benzodiazepine Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Benzodiazepine
10.2.4 Benzodiazepine Product Introduction
10.2.5 Eli Lilly Recent Development
10.3 Forest Laboratories
10.3.1 Forest Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Benzodiazepine
10.3.4 Benzodiazepine Product Introduction
10.3.5 Forest Laboratories Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Benzodiazepine
10.4.4 Benzodiazepine Product Introduction
10.4.5 GlaxoSmithKline Recent Development
10.5 H. Lundbeck
10.5.1 H. Lundbeck Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Benzodiazepine
10.5.4 Benzodiazepine Product Introduction
10.5.5 H. Lundbeck Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Benzodiazepine
10.6.4 Benzodiazepine Product Introduction
10.6.5 Johnson & Johnson Recent Development
10.7 Merck & Co
10.7.1 Merck & Co Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Benzodiazepine
10.7.4 Benzodiazepine Product Introduction
10.7.5 Merck & Co Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Benzodiazepine
10.8.4 Benzodiazepine Product Introduction
10.8.5 Pfizer Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Benzodiazepine
10.9.4 Benzodiazepine Product Introduction
10.9.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Benzodiazepine Sales Channels
11.2.2 Benzodiazepine Distributors
11.3 Benzodiazepine Customers
12 Market Forecast
12.1 Global Benzodiazepine Sales and Revenue Forecast 2019-2025
12.2 Global Benzodiazepine Sales Forecast by Type
12.3 Global Benzodiazepine Sales Forecast by Application
12.4 Benzodiazepine Forecast by Regions
12.4.1 Global Benzodiazepine Sales Forecast by Regions 2019-2025
12.4.2 Global Benzodiazepine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Benzodiazepine Market Size Growth Rate by Type (2019-2025)
1.3.2 Long acting
1.3.3 Short acting
1.4 Market Segment by Application
1.4.1 Global Benzodiazepine Market Share by Application (2019-2025)
1.4.2 Anxiety
1.4.3 Insomnia
1.4.4 Agitation
1.4.5 Seizures
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Benzodiazepine Market Size
2.1.1 Global Benzodiazepine Revenue 2014-2025
2.1.2 Global Benzodiazepine Sales 2014-2025
2.2 Benzodiazepine Growth Rate by Regions
2.2.1 Global Benzodiazepine Sales by Regions 2014-2019
2.2.2 Global Benzodiazepine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Benzodiazepine Sales by Manufacturers
3.1.1 Benzodiazepine Sales by Manufacturers 2014-2019
3.1.2 Benzodiazepine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Benzodiazepine Revenue by Manufacturers (2014-2019)
3.2.2 Benzodiazepine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Benzodiazepine Market Concentration Ratio (CR5 and HHI)
3.3 Benzodiazepine Price by Manufacturers
3.4 Key Manufacturers Benzodiazepine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Benzodiazepine Market
3.6 Key Manufacturers Benzodiazepine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Long acting Sales and Revenue (2014-2019)
4.1.2 Short acting Sales and Revenue (2014-2019)
4.2 Global Benzodiazepine Sales Market Share by Type
4.3 Global Benzodiazepine Revenue Market Share by Type
4.4 Benzodiazepine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Benzodiazepine Sales by Application
6 United States
6.1 United States Benzodiazepine Breakdown Data by Company
6.2 United States Benzodiazepine Breakdown Data by Type
6.3 United States Benzodiazepine Breakdown Data by Application
7 European Union
7.1 European Union Benzodiazepine Breakdown Data by Company
7.2 European Union Benzodiazepine Breakdown Data by Type
7.3 European Union Benzodiazepine Breakdown Data by Application
8 China
8.1 China Benzodiazepine Breakdown Data by Company
8.2 China Benzodiazepine Breakdown Data by Type
8.3 China Benzodiazepine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Benzodiazepine Breakdown Data by Company
9.2 Rest of World Benzodiazepine Breakdown Data by Type
9.3 Rest of World Benzodiazepine Breakdown Data by Application
9.4 Rest of World Benzodiazepine Breakdown Data by Countries
9.4.1 Rest of World Benzodiazepine Sales by Countries
9.4.2 Rest of World Benzodiazepine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Benzodiazepine
10.1.4 Benzodiazepine Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Benzodiazepine
10.2.4 Benzodiazepine Product Introduction
10.2.5 Eli Lilly Recent Development
10.3 Forest Laboratories
10.3.1 Forest Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Benzodiazepine
10.3.4 Benzodiazepine Product Introduction
10.3.5 Forest Laboratories Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Benzodiazepine
10.4.4 Benzodiazepine Product Introduction
10.4.5 GlaxoSmithKline Recent Development
10.5 H. Lundbeck
10.5.1 H. Lundbeck Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Benzodiazepine
10.5.4 Benzodiazepine Product Introduction
10.5.5 H. Lundbeck Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Benzodiazepine
10.6.4 Benzodiazepine Product Introduction
10.6.5 Johnson & Johnson Recent Development
10.7 Merck & Co
10.7.1 Merck & Co Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Benzodiazepine
10.7.4 Benzodiazepine Product Introduction
10.7.5 Merck & Co Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Benzodiazepine
10.8.4 Benzodiazepine Product Introduction
10.8.5 Pfizer Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Benzodiazepine
10.9.4 Benzodiazepine Product Introduction
10.9.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Benzodiazepine Sales Channels
11.2.2 Benzodiazepine Distributors
11.3 Benzodiazepine Customers
12 Market Forecast
12.1 Global Benzodiazepine Sales and Revenue Forecast 2019-2025
12.2 Global Benzodiazepine Sales Forecast by Type
12.3 Global Benzodiazepine Sales Forecast by Application
12.4 Benzodiazepine Forecast by Regions
12.4.1 Global Benzodiazepine Sales Forecast by Regions 2019-2025
12.4.2 Global Benzodiazepine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
